The latest 5th edition recently refined the diagnosis of glioblastoma by adopting a multi-layered integrated approach incorporating new molecular criteria such as TERT promoter mutation, EGFR amplification or chromosomal 7 + gain / chromosomal 10- loss for IDH-1 wildtype tumors. Here, IDH1 is linked to glioblastoma.